Burleson & Company, LLC Eli Lilly & CO Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

A detailed history of Burleson & Company, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Burleson & Company, LLC holds 25,979 shares of LLY stock, worth $20.7 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares

25,979

Previous 25,747 0.9%

Holding current value

$20.7 Million

Previous $8.33 Million 14.16%

% of portfolio

2.48%

Previous 1.79%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$321.55 - $374.67 $74,599 - $86,923	232 Added 0.9%	25,979 $9.5 Million
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $87,461 - $99,671	295 Added 1.16%	25,747 $8.33 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $94,489 - $110,944	-339 Reduced 1.31%	25,452 $8.25 Million
Q1 2022 Apr 25, 2022	BUY	$234.69 - $291.66 $2.34 Million - $2.91 Million	9,977 Added 63.09%	25,791 $7.39 Million
Q4 2021 Jan 25, 2022	SELL	$224.85 - $279.04 $247,110 - $306,664	-1,099 Reduced 6.5%	15,814 $4.37 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $13,541 - $17,515	75 Added 0.45%	16,913 $3.88 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $5,000 - $6,188	-42 Reduced 0.25%	16,838 $2.59 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $106 - $132	1 Added 0.01%	16,880 $2.39 Million
Q4 2018 Feb 27, 2019	SELL	$105.9 - $118.64 $5,612 - $6,287	-53 Reduced 0.31%	16,879 $2.07 Million
Q3 2018 Dec 06, 2018	SELL	$85.86 - $107.31 $36,232 - $45,284	-422 Reduced 2.43%	16,932 $1.96 Million
Q2 2018 Jul 31, 2018	SELL	$75.7 - $86.88 $12,339 - $14,161	-163 Reduced 0.93%	17,354 $1.48 Million
Q1 2018 Apr 23, 2018	BUY	$74.21 - $87.6 $296 - $350	4 Added 0.02%	17,517 $1.36 Million
Q4 2017 Mar 19, 2018	BUY	$81.94 - $87.89 $1.44 Million - $1.54 Million	17,513	17,513 $1.48 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.

Account

Burleson & Company, LLC Eli Lilly & CO Transaction History